Nitrase Therapeutics

nitrasetx.com

Actively hiring

Overview

Salaries

Products

People

Growth

Offices

Financials

Overview

Transforming the Treatment of Parkinson’s Disease Our lead program, NDC-0524, is a specially designed antibody that targets a modified, pathologic form of a neuronal protein called alpha-synuclein.